Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAFCILLIN vs NALBUPHINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAFCILLIN vs NALBUPHINE: Safety Overview

Metric NAFCILLIN NALBUPHINE
Total FAERS Reports 215 702
Deaths Reported 18 78
Death Rate 8.4% 11.1%
Hospitalizations 98 95
Average Patient Age 50.7 yrs 42.1 yrs
% Female Patients 50.5% 63.5%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Eugia US LLC Henry Schein, Inc.
Route INTRAVENOUS INTRAMUSCULAR
Marketing Status Discontinued Discontinued